Search Results - "American journal of hematology"

Hematological findings and complications of COVID‐19 by Terpos, Evangelos, Ntanasis‐Stathopoulos, Ioannis, Elalamy, Ismail, Kastritis, Efstathios, Sergentanis, Theodoros N., Politou, Marianna, Psaltopoulou, Theodora, Gerotziafas, Grigoris, Dimopoulos, Meletios A.

“…COVID‐19 is a systemic infection with a significant impact on the hematopoietic system and hemostasis. Lymphopenia may be considered as a cardinal laboratory…”
Get full text

Multiple myeloma: 2022 update on diagnosis, risk stratification, and management by Rajkumar, S. Vincent

“…Disease Overview Multiple myeloma accounts for approximately 10% of hematologic malignancies. Diagnosis The diagnosis requires ≥10% clonal bone marrow plasma…”
Get full text

Hematologic parameters in patients with COVID‐19 infection by Fan, Bingwen Eugene, Chong, Vanessa Cui Lian, Chan, Stephrene Seok Wei, Lim, Gek Hsiang, Lim, Kian Guan Eric, Tan, Guat Bee, Mucheli, Sharavan Sadasiv, Kuperan, Ponnudurai, Ong, Kiat Hoe

Get full text

Multiple myeloma: 2020 update on diagnosis, risk‐stratification and management by Rajkumar, S. Vincent

“…Disease overview Multiple myeloma accounts for approximately 10% of hematologic malignancies. Diagnosis The diagnosis requires ≥10% clonal bone marrow plasma…”
Get full text

Thrombocytopenia following Pfizer and Moderna SARS‐CoV‐2 vaccination by Lee, Eun‐Ju, Cines, Douglas B., Gernsheimer, Terry, Kessler, Craig, Michel, Marc, Tarantino, Michael D., Semple, John W., Arnold, Donald M., Godeau, Bertrand, Lambert, Michele P., Bussel, James B.

Get full text

Final analysis from RESONATE: Up to six years of follow‐up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma by Munir, Talha, Brown, Jennifer R., O'Brien, Susan, Barrientos, Jacqueline C., Barr, Paul M., Reddy, Nishitha M., Coutre, Steven, Tam, Constantine S., Mulligan, Stephen P., Jaeger, Ulrich, Kipps, Thomas J., Moreno, Carol, Montillo, Marco, Burger, Jan A., Byrd, John C., Hillmen, Peter, Dai, Sandra, Szoke, Anita, Dean, James P., Woyach, Jennifer A.

“…Ibrutinib, a once‐daily oral inhibitor of Bruton's tyrosine kinase, is approved in the United States and Europe for treatment of patients with chronic…”
Get full text

Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment by Hallek, Michael

“…Disease overview Chronic lymphocytic leukemia (CLL) is the commonest leukemia in western countries. The disease typically occurs in elderly patients and has a…”
Get full text

Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures by Hallek, Michael, Al‐Sawaf, Othman

“…Disease overview Chronic lymphocytic leukemia (CLL) is one of the most frequent types of leukemia. It typically occurs in elderly patients and has a highly…”
Get full text

An introduction to chimeric antigen receptor (CAR) T‐cell immunotherapy for human cancer by Feins, Steven, Kong, Weimin, Williams, Erik F., Milone, Michael C., Fraietta, Joseph A.

“…Chimeric antigen receptor (CAR) T‐cell therapy represents a major advancement in personalized cancer treatment. In this strategy, a patient's own T cells are…”
Get full text

Thrombosis in COVID‐19 by Hanff, Thomas C., Mohareb, Amir M., Giri, Jay, Cohen, Jordana B., Chirinos, Julio A.

“…Thrombotic complications are frequent in COVID‐19 and contribute significantly to mortality and morbidity. We review several mechanisms of hypercoagulability…”
Get full text

Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk‐stratification and management by Tefferi, Ayalew, Barbui, Tiziano

“…Disease overview Polycythemia vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms (MPN) respectively characterized by clonal…”
Get full text

Primary myelofibrosis: 2021 update on diagnosis, risk‐stratification and management by Tefferi, Ayalew

“…Disease Overview Primary myelofibrosis (PMF) is a myeloproliferative neoplasm (MPN) characterized by stem cell‐derived clonal myeloproliferation that is often…”
Get full text

Acute myeloid leukemia: 2023 update on diagnosis, risk‐stratification, and management by Shimony, Shai, Stahl, Maximilian, Stone, Richard M.

“…Disease overview Acute myeloid leukemia (AML) is a frequently fatal bone marrow stem cell cancer characterized by unbridled proliferation of malignant marrow…”
Get full text

Diffuse large B‐cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment by Liu, Yang, Barta, Stefan Klaus

“…Disease Overview Diffuse large B‐cell lymphoma (DLBCL) is the most common type of aggressive non‐Hodgkin lymphoma originating from the germinal center, and it…”
Get full text

Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring by Jabbour, Elias, Kantarjian, Hagop

“…Disease overview Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm with an incidence of 1‐2 cases per 100 000 adults. It accounts for…”
Get full text

2021 Update on Diffuse large B cell lymphoma: A review of current data and potential applications on risk stratification and management by Susanibar‐Adaniya, Sandra, Barta, Stefan K.

“…Diffuse large B cell lymphoma (DLBCL), the most common type of Non‐Hodgkin lymphoma (NHL), comprises a heterogeneous group of diseases with different biology,…”
Get full text

Clinical experience with the BCL2‐inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies by DiNardo, Courtney D., Rausch, Caitlin R., Benton, Christopher, Kadia, Tapan, Jain, Nitin, Pemmaraju, Naveen, Daver, Naval, Covert, Wendy, Marx, Kayleigh R., Mace, Morgan, Jabbour, Elias, Cortes, Jorge, Garcia‐Manero, Guillermo, Ravandi, Farhad, Bhalla, Kapil N., Kantarjian, Hagop, Konopleva, Marina

“…Introduction Venetoclax (VEN), a selective BCL2 inhibitor, has single‐agent activity in relapsed and refractory (R/R) acute myeloid leukemia (AML), and…”
Get full text

Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum by Cuker, Adam, Burnett, Allison, Triller, Darren, Crowther, Mark, Ansell, Jack, Van Cott, Elizabeth M., Wirth, Diane, Kaatz, Scott

“…Two specific reversal agents for direct oral anticoagulants (DOACs) have been approved in the United States: idarucizumab for dabigatran reversal and andexanet…”
Get full text

Acute myeloid leukemia: 2019 update on risk‐stratification and management by Estey, Elihu H.

“…Outcome in patients with acute myeloid leukemia (AML) ranges from death within a few days of beginning treatment (treatment related mortality, TRM) to likely…”
Get full text

Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management by Cappellini, Maria Domenica, Comin-Colet, Josep, de Francisco, Angel, Dignass, Axel, Doehner, Wolfram, Lam, Carolyn S, Macdougall, Iain C, Rogler, Gerhard, Camaschella, Clara, Kadir, Rezan, Kassebaum, Nicholas J, Spahn, Donat R, Taher, Ali T, Musallam, Khaled M

“…Iron deficiency, even in the absence of anemia, can be debilitating, and exacerbate any underlying chronic disease, leading to increased morbidity and…”
Get full text